We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-11.4%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$57.4B
AUM Growth
-$7.29B
Cap. Flow
+$861M
Cap. Flow %
1.5%
Top 10 Hldgs %
21.3%
Holding
3,843
New
205
Increased
1,398
Reduced
1,819
Closed
309

Sector Composition

Rank Sector Weight
1 Technology 9.78%
2 Financials 8.85%
3 Healthcare 8.68%
4 Industrials 6.29%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XES icon
3201
State Street SPDR S&P Oil & Gas Equipment & Services ETF
XES
$389M
$150K ﹤0.01%
1,669
-2,321
-58% -$301K
BKT icon
3202
BlackRock Income Trust
BKT
$342M
$149K ﹤0.01%
8,781
-484
-5% -$8.22K
SAND
3203
DELISTED
Sandstorm Gold
SAND
$149K ﹤0.01%
32,274
+1,034
+3% +$4.2K
DRH icon
3204
Diamondrock Hospitality Co
DRH
$2.47B
$147K ﹤0.01%
16,161
+2,700
+20% +$27.8K
ARRY
3205
DELISTED
Array Biopharma Inc
ARRY
$147K ﹤0.01%
+10,297
New +$156K
GLV
3206
Clough Global Dividend & Income Fund
GLV
$78.7M
$146K ﹤0.01%
14,640
-8,842
-38% -$98.8K
UWN
3207
DELISTED
Nevada Gold & Casinos, Ltd.
UWN
$146K ﹤0.01%
61,240
GE icon
3208
PUT
GE Aerospace
GE
$383B
$145K ﹤0.01%
23,641
+17,214
+268% +$777K
ADAM
3209
Adamas Trust
ADAM
$923M
$145K ﹤0.01%
6,168
+1,040
+20% +$25.2K
TVRD
3210
Tvardi Therapeutics
TVRD
$22.2M
$145K ﹤0.01%
310
-64
-17% -$41.3K
NXP icon
3211
Nuveen Select Tax-Free Income Portfolio
NXP
$897M
$144K ﹤0.01%
+10,244
New +$143K
PVL
3212
Permianville Royalty Trust
PVL
$57.8M
$143K ﹤0.01%
75,812
VATE icon
3213
INNOVATE Corp
VATE
$105M
$143K ﹤0.01%
+5,416
New +$228K
VSTM icon
3214
Verastem
VSTM
$641M
$142K ﹤0.01%
3,534
-400
-10% -$24.4K
GME icon
3215
GameStop
GME
$8.4B
$141K ﹤0.01%
+44,540
New +$156K
OSUR icon
3216
OraSure Technologies
OSUR
$272M
$141K ﹤0.01%
12,091
-2,255
-16% -$30K
KSM
3217
DELISTED
DWS Strategic Municipal Income Trust
KSM
$141K ﹤0.01%
+13,680
New +$141K
BKD icon
3218
Brookdale Senior Living
BKD
$3.1B
$140K ﹤0.01%
20,900
MDR
3219
DELISTED
McDermott International
MDR
$140K ﹤0.01%
21,404
-15,141
-41% -$160K
PFD
3220
Flaherty & Crumrine Preferred and Income Fund
PFD
$146M
$138K ﹤0.01%
+11,958
New +$146K
CASA
3221
DELISTED
Casa Systems, Inc. Common Stock
CASA
$138K ﹤0.01%
10,510
-1,675
-14% -$24K
TGP
3222
DELISTED
Teekay LNG Partners L.P.
TGP
$138K ﹤0.01%
12,481
+503
+4% +$7.09K
TRMT
3223
DELISTED
Tremont Mortgage Trust Common Shares of Beneficial Interest
TRMT
$137K ﹤0.01%
15,100
+1,000
+7% +$10.6K
SLGL icon
3224
Sol-Gel Technologies
SLGL
$275M
$136K ﹤0.01%
2,266
-210
-8% -$13.9K
GDP
3225
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
$136K ﹤0.01%
10,078
-6,596
-40% -$92.9K

Similar funds

Raymond James & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Raymond James & Associates held 3,843 positions worth $57.4B, down 11% from $64.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q4 2018 filing shows 205 new, 1,398 increased, 1,819 reduced and 309 closed positions. Its largest new stake was Linde: 549,404 shares worth $87.1M. The largest sale was Oracle, an estimated $124M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2018 buy was Linde: 549,404 shares worth $87.1M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $368M increase.
  • Raymond James & Associates's biggest Q4 2018 reduction was Oracle, cutting an estimated $124M.
  • Raymond James & Associates fully exited Praxair Inc in Q4 2018, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $57.4B portfolio in Q4 2018.
  • Raymond James & Associates opened 205 new positions and closed 309 in Q4 2018.
  • Raymond James & Associates's portfolio value fell 11% quarter-over-quarter to $57.4B.

Based on Raymond James & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.